First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody–Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
2020 · Journal of Clinical Oncology · 164 citations
https://doi.org/10.1200/jco.19.02085